Connor, Clark & Lunn Investment Management (CC&L)’s Carisma Therapeutics CARM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,043
| Closed | -$29.6K | – | 1406 |
|
|
2024
Q1 | $29.6K | Buy |
+13,043
| New | +$29.6K | ﹤0.01% | 1494 |
|
|
2023
Q3 | – | Sell |
-14,796
| Closed | -$130K | – | 1378 |
|
|
2023
Q2 | $130K | Hold |
14,796
| – | – | ﹤0.01% | 1235 |
|
|
2023
Q1 | $45.9K | Buy |
14,796
+6,921
| +88% | +$21.5K | ﹤0.01% | 1193 |
|
|
2022
Q4 | $96K | Buy |
7,875
+737
| +10% | +$8.98K | ﹤0.01% | 1109 |
|
|
2022
Q3 | $61K | Buy |
+7,138
| New | +$61K | ﹤0.01% | 1060 |
|
|
2016
Q1 | – | Sell |
-1,275
| Closed | -$77K | – | 835 |
|
|
2015
Q4 | $77K | Hold |
1,275
| – | – | ﹤0.01% | 771 |
|
|
2015
Q3 | $61K | Buy |
1,275
+120
| +10% | +$5.74K | ﹤0.01% | 683 |
|
|
2015
Q2 | $65K | Buy |
+1,155
| New | +$65K | ﹤0.01% | 603 |
|